Abstract
Laser Scanning Confocal Microscopy (LSCM) imaging using an appropriate fluorescent probe enables the visualization of a molecular target with high resolution, and represents a method of choice for studying expression, subcellular location, and trafficking of receptors in living cells. The chemical, physical, and pharmacological properties of the probe remain essential. Here, we describe (1) the preparation of a specific probe for NMDAR GluN2B receptor by conjugation of fluorescein to an ifenprodil-based ligand, (2) an in vitro functional assay by calcium imaging for GluN2B binding and inhibition evaluation of the probe, and (3) the labeling and confocal imaging of GluN2B in DS-red labeled living cortical neurons.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sanz-Clemente A, Nicoll RA, Roche KW (2013) Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist 19:62–75
Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405–496
Laube B, Kuhse J, Betz H (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 18:2954–2961
Loftis JM, Janowsky A (2003) The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97:55–85
Paoletti P (2011) Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33:1351–1365
Papouin T, Oliet SHR (2014) Organization, control and function of extrasynaptic NMDA receptors. Philos Trans R Soc Lond B Biol Sci 369(1654):20130601
Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004(255):re16
Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682–696
Parsons MP, Raymond LA (2014) Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 82:279–293
Sousa JB, Frescol P, Diniz C (2014) Imaging receptors with Laser Scanning Confocal Microscopy: qualitative and quantitative analysis. In: Méndes-Vilas A (ed) Microscopy: advances in scientific research and education, Microscopy book series #6, vol 1. Formatex Research Center Publisher, Badajoz, Spain, pp 201–208
McGrath JC, Arribas S, Daly CJ (1996) Fluorescent ligands for the study of receptors. Trends Pharmacol Sci 17:393–399
Masuko T, Kashiwagi K, Kuno T, Nguyen ND, Pahk AJ, Fukuchi J, Igarashi K, Williams K (1999) A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol Pharmacol 55:957–969
Perin-Dureau F, Rachline J, Neyton J, Paoletti P (2002) Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci 22:5955–5965
Mony L, Krzaczkowski L, Leonetti M, Le Goff A, Alarcon K, Neyton J, Bertrand H-O, Acher F, Paoletti P (2009) Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. Mol Pharmacol 75:60–74
Ng F-M, Geballe MT, Snyder JP, Traynelis SF, Low C-M (2008) Structural insights into phenylethanolamines highaffinity binding site in NR2B from binding and molecular modeling studies. Mol Brain 1:1–11
Reynold IJ, Miller R (1989) Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Mol Pharmacol 36:758–765
Williams K (2001) Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action. Curr Drug Targets 2:285–298
Borza I, Domany G (2006) NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore. Curr Top Med Chem 6:687–695
Layton ME, Kelly MJ, Rodzinak KJ (2006) Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists. Curr Top Med Chem 6:697–709
MacCauley JA (2006) Amide-containing NR2B/NMDA receptor antagonists. Expert Opin Ther Patents 16:863–870
MacCauley JA (2005) NR2B subtype-selective NMDA receptor antagonists: 2001−2004. Expert Opin Ther Patents 15:389–407
Nikam SS, Meltzer LT (2002) NR2B selective NMDA receptor antagonists. Curr Pharm Des 8:845–855
Rosahl TW, Wingrove PB, Hunt V, Fradley RL, Lawrence JMK, Heavens RP, Treacey P, Usala M, Macauley A, Bonnert TP, Whiting PJ, Wafford KA (2006) A genetically modified mouse model probing the selective action of ifenprodil at the N-methyl-D-aspartate type 2B receptor. Mol Cell Neurosci 33:47–56
Grimwood S, Richards P, Murray F, Harrison N, Wingrove PB, Hutson PH (2000) Characterisation of N-methyl-Daspartate receptor-specific [3H]ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes. J Neurochem 75:2455–2463
Avenet P, Leonardon J, Besnard F, Graham D, Frost J, Depoortere H, Langer SZ, Scatton B (1996) Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Eur J Pharmacol 296:209–213
Marchand P, Becerril-Ortega J, Mony L, Bouteiller C, Paoletti P, Nicole O, Barré L, Buisson A, Perrio C (2012) Confocal microscopy imaging of NR2B containing NMDA receptor using fluorescent ifenprodil-based conjugates. Bioconjug Chem 23:2126
Dhilly M, Becerril-Ortega J, Colloc’h N, MacKenzie ET, Barré L, Buisson A, Nicole O, Perrio C (2013) Synthesis and in vitro characterization of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-Aspartate receptor antagonists. Chembiochem 14:759769
Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7–61
Sim N, Gottschalk S, Pal R, Delbianco M, Degtyaruk O, Razansky D, Westmeyer GG, Ntziachristos V, Parker D, Mishra A (2015) Wavelength-dependent optoacoustic imaging probes for NMDA receptor visualization. Chem Commun 51:15149–15152
Léveillé F, El Gaamouch F, Gouix E, Lecocq M, Lobner D, Nicole O, Buisson A (2008) Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J 22:4258–4271
Acknowledgment
This work was supported by the CNRS, CEA and UNICAEN for financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Perrio, C., Nicole, O., Buisson, A. (2017). GluN2B Subunit Labeling with Fluorescent Probes and High-Resolution Live Imaging. In: Burnashev, N., Szepetowski, P. (eds) NMDA Receptors. Methods in Molecular Biology, vol 1677. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7321-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7321-7_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7320-0
Online ISBN: 978-1-4939-7321-7
eBook Packages: Springer Protocols